New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effec ...

The World Health Organisation (WHO) has for the first time recommended the use of injectable lenacapavir (LEN) as a ...

A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...

There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between with US ...

In this edition of STAT's Health Tech newsletter: A new study looked at the evidence behind medical devices deemed "breakthrough' by the FDA.

Health New HIV prevention shot touted as breakthrough: HealthLink HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.